Bank of Montreal
AVDL

Bank of Montreal’s Avadel Pharmaceuticals AVDL Stock Holding History

Bank of Montreal’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-39,500
Closed -$286K – 4621
2020
Q1 		$286K Buy
39,500
+39,200
+13,067% +$301K ﹤0.01% 2209
2019
Q4 		$2K Buy
+300
New +$1.58K ﹤0.01% 4768
2019
Q2 		– Sell
-1,066
Closed -$2K – 4848
2019
Q1 		$2K Sell
1,066
-2,915
-73% -$6.59K ﹤0.01% 4135
2018
Q4 		$10K Hold
3,981
– – ﹤0.01% 3876
2018
Q3 		$17K Sell
3,981
-1,000
-20% -$5.4K ﹤0.01% 3754
2018
Q2 		$30K Hold
4,981
– – ﹤0.01% 3603
2018
Q1 		$36K Hold
4,981
– – ﹤0.01% 3361
2017
Q4 		$41K Buy
4,981
+1,000
+25% +$9.38K ﹤0.01% 3335
2017
Q3 		$42K Hold
3,981
– – ﹤0.01% 3282
2017
Q2 		$44K Hold
3,981
– – ﹤0.01% 3268
2017
Q1 		$39K Hold
3,981
– – ﹤0.01% 3165
2016
Q4 		$42K Sell
3,981
-310
-7% -$3.41K ﹤0.01% 3166
2016
Q3 		$53K Hold
4,291
– – ﹤0.01% 3031
2016
Q2 		$46K Buy
4,291
+310
+8% +$3.31K ﹤0.01% 3090
2016
Q1 		$44K Buy
3,981
+2,463
+162% +$24.5K ﹤0.01% 3098
2015
Q4 		$19K Buy
+1,518
New +$23.7K ﹤0.01% 3414

Other funds holding AVDL

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Bank of Montreal's AVDL Position: Q2 2020 in Review

Bank of Montreal sold out of Avadel Pharmaceuticals (AVDL) in Q2 2020, closing a stake of 39,500 shares — an estimated $286K sold.

Bank of Montreal first reported a position in AVDL in Q4 2015 and held it in 16 quarters. The position peaked at $286K in Q1 2020. 74 funds tracked by Wall St. Rank hold AVDL as of Q2 2020.

  • Bank of Montreal reported no remaining Avadel Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Bank of Montreal sold 39,500 Avadel Pharmaceuticals shares in Q2 2020, an estimated $286K.
  • Bank of Montreal first reported a position in Avadel Pharmaceuticals in Q4 2015 and held it in 16 quarters.
  • Bank of Montreal's Avadel Pharmaceuticals position peaked at $286K in Q1 2020.
  • 74 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q2 2020.

Based on Bank of Montreal's 13F filing for Q2 2020, filed 12 Aug 2020.